Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Systemic lupus erythematosus
•
Dermatology
Do you have concerns about the use of red light therapy in a patient with lupus?
Related Questions
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
How do you manage recalcitrant tumid lupus in a patient with partial response to antimalarials and off-label apremilast, in the setting of coexisting MDS with significant neutropenia?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
How do you approach new-onset idiopathic intracranial hypertension (IIH) with someone who has history of systemic lupus erythematosus?
Do you check IgA levels before starting IVIG for other autoimmune conditions?
What are some practical tips for tacrolimus management/monitoring in SLE nephritis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How should rheumatologists address the impact on patients who are initially diagnosed with SLE based on positive ANA, but later reclassified as having UCTD?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
How do you treat a patient with new class V lupus nephritis and recent hx of breast cancer on tamoxifen?
